FD Dos Reis, C Jerónimo, MP Correia - Frontiers in Immunology, 2023 - frontiersin.org
Immunoepigenetics is a growing field, as there is mounting evidence on the key role played by epigenetic mechanisms in the regulation of tumor immune cell recognition and control of …
DC Kirkey, AM Loeb, S Castro, CN McKay… - Blood …, 2023 - ashpublications.org
Abstract Preferentially Expressed Antigen in Melanoma (PRAME), a cancer-testis antigen, provides an ideal target for immunotherapy in acute myeloid leukemia (AML). We have …
Y Iwasa, T Nakajima, K Hori, Y Yokota, R Kitoh… - Biomolecules, 2023 - mdpi.com
Although anti-programmed death-1 (PD-1) antibody therapy improves the prognosis in patients with head and neck squamous cell carcinoma (HNSCC), some patients exhibit …
M Zhu, N Li, L Fan, R Wu, L Cao, Y Ren, C Lu… - Blood Cancer …, 2024 - nature.com
Angioimmunoblastic T-cell lymphoma (AITL) is a kind of aggressive T-cell lymphoma with significant enrichment of non-malignant tumor microenvironment (TME) cells. However, the …
SK Pai, K Chakraborty, AA Pai, S Dhara - Journal of Applied Phycology, 2024 - Springer
Sulfated polysaccharides derived from green marine macroalgae are known for their wide range of therapeutic properties, including the mitigation of inflammatory disorders. A sulfated …
N Dong, L Perez-Lamas, JC Chavez - Expert Opinion on Emerging …, 2023 - Taylor & Francis
Introduction Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma. Recent advances in immunotherapy such as chimeric antigen receptor T-cell …
AA Mensah, P Mondello - Journal of clinical medicine, 2022 - mdpi.com
The last two decades have brought ground-breaking advances in genetics, culminating in deep profiling of the human genome and high resolution detection of genetic variants. These …
JS Delisle, MF Aubin - … vol 2‐Immunologic Approaches for the …, 2024 - Wiley Online Library
Multiple types of MHC‐associated antigens can be targeted in lymphoid malignancies. Tumor‐associated antigens (TAA) are abnormally expressed self‐antigens. TAA‐based …